^
BIOMARKER:

HR positive

i
Other names: ESR1, Era, ESR, NR3A1, ER, ER beta, PGR, Progesterone receptor, Nuclear receptor subfamily 3 group C member 3, NR3C3
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
HR positive
HER2 Negative Breast Cancer
palbociclib
Sensitive
:
A1
NICE - 3 days - (New A2)
HR positive
HER2 Negative Breast Cancer
sacituzumab govitecan-hziy
Sensitive
:
A2
ESMO 2022 - 3 weeks - (New B)
HR positive
HER2 Negative Breast Cancer
dalpiciclib
Sensitive
:
B
ESMO 2022 - 3 weeks - (New B)
HR positive
HER2 Positive Breast Cancer
trastuzumab + abemaciclib
Sensitive
:
C3
ESMO 2022 - 3 weeks - (New C3)
HR positive
HER2 Positive Breast Cancer
neratinib
Sensitive
:
A1
HR positive
HER2 Negative Breast Cancer
ribociclib
Sensitive
:
A1
HR positive
HER2 Negative Breast Cancer
abemaciclib
Sensitive
:
A1
HR positive
Hormone Receptor Positive Breast Cancer
ribociclib
Sensitive
:
A1
HR positive
HER2 Negative Breast Cancer
everolimus
Sensitive
:
A1
HR positive
HER2 Positive Breast Cancer
Zercepac (trastuzumab biosimilar)
Sensitive
:
A1
HR positive
Hormone Receptor Positive Breast Cancer
olaparib
Sensitive
:
A1
HR positive
Hormone Receptor Positive Breast Cancer
letrozole
Sensitive
:
A1
HR positive
Hormone Receptor Positive Breast Cancer
anastrozole
Sensitive
:
A1
HR positive
Hormone Receptor Positive Breast Cancer
talazoparib
Sensitive
:
A1
HR positive
Hormone Receptor Positive Breast Cancer
fulvestrant
Sensitive
:
A1
HR positive
HER2 Negative Breast Cancer
fulvestrant
Sensitive
:
A1
HR positive
HER2 Positive Breast Cancer
trastuzumab
Sensitive
:
A2
HR positive
HER2 Positive Breast Cancer
lapatinib
Sensitive
:
A2
HR positive
HER2 Positive Breast Cancer
trastuzumab + pertuzumab
Sensitive
:
A2
HR positive
HER2 Negative Breast Cancer
toremifene
Sensitive
:
A2
HR positive
HER2 Positive Breast Cancer
HER2 inhibitor
Sensitive
:
A2
HR positive
HER2 Positive Breast Cancer
HER2 inhibitor + Aromatase inhibitor
Sensitive
:
A2
HR positive
Male Breast Cancer
Aromatase inhibitor
Sensitive
:
A2
HR positive
Male Breast Cancer
tamoxifen
Sensitive
:
A2
HR positive
Hormone Receptor Positive Breast Cancer
palbociclib
Resistant
:
A2
HR positive
HER2 Negative Breast Cancer
Aromatase inhibitor
Sensitive
:
A2
HR positive
Hormone Receptor Positive Breast Cancer
everolimus
Sensitive
:
A2
HR positive
HER2 Negative Breast Cancer
fulvestrant
Sensitive
:
A2
HR positive
HER2 Negative Breast Cancer
letrozole
Sensitive
:
A2
HR positive
HER2 Positive Breast Cancer
trastuzumab + lapatinib
Sensitive
:
A2
HR positive
HER2 Positive Breast Cancer
Aromatase inhibitor
Sensitive
:
A2
HR positive
HER2 Negative Breast Cancer
estradiol
Sensitive
:
A2
HR positive
HER2 Negative Breast Cancer
megestrol
Sensitive
:
A2
HR positive
Hormone Receptor Positive Breast Cancer
Aromatase inhibitor + palbociclib
Sensitive
:
A2
HR positive
Hormone Receptor Positive Breast Cancer
Aromatase inhibitor
Sensitive
:
A2
HR positive
HER2 Negative Breast Cancer
eribulin mesylate
Sensitive
:
A2